ARS Pharmaceuticals (SPRY) EBIT Margin (2022 - 2026)
ARS Pharmaceuticals (SPRY) reported EBIT Margin of -182.62% for Q2 2026, up 120.33 percentage points from -302.95% a year earlier and up 82.56 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) EBIT Margin (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ARS Pharmaceuticals' EBIT Margin came in at -184.96%, down 132.13 percentage points year-over-year; for FY2025, it was -212.92%, down 209.47 percentage points from FY2024.
- EBIT Margin has a four-year change of +140.40 percentage points (FY2021 to FY2025).
- By year, EBIT Margin came in at -3.46% in FY2024 (+225063.21 pp), -225066.67% in FY2023 (-222367.88 pp), -2698.78% in FY2022 (-2345.46 pp) and -353.32% in FY2021.
- Five-year quarterly EBIT Margin spans a low of -206030.00% in Q2 2023 and a high of 54.51% in Q4 2024.
- Year over year, EBIT Margin gained in four of the last five quarters, with an average year-over-year change of +754.47 percentage points.
- The high point for year-over-year EBIT Margin in five years was Q2 2024 (a gain of 202962.00 percentage points); the low point was Q2 2023 (a drop of 204662.76 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -265.18% (Q1 2026), -147.63% (Q4 2025) and -163.66% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | -182.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -182.62% |
| Mar 31, 2026 | -265.18% |
| Dec 31, 2025 | -147.63% |
| Sep 30, 2025 | -163.66% |
| Jun 30, 2025 | -302.95% |
| Mar 31, 2025 | -466.29% |
| Dec 31, 2024 | 54.51% |
| Sep 30, 2024 | -1,051.64% |
| Jun 30, 2024 | -3,068.00% |
| Jun 30, 2023 | -206,030.00% |
| Mar 31, 2023 | -93,565.00% |
| Sep 30, 2022 | -3,507.94% |
| Jun 30, 2022 | -1,367.24% |
| Mar 31, 2022 | -1,070.74% |
API Access
ARS Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();